Patent · US Active

Pyrimidooxazocine derivatives as mTOR-inhibitors

US9120812B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

Sanofi · FR

Inventors

Alain Braun · Antony, FR
Olivier Crespin · Paris, FR
Yann Foricher · Riedisheim, FR
Gilbert Marciniak · Paris, FR
Nicolas Muzet · Paris, FR
Eric Nicolai · Paris, FR
Cecile Pascal · Paris, FR
Bertrand Vivet · Paris, FR
Fabrice Viviani · Avenheim, FR

Key dates

Filing date	Jan 25, 2013
Grant date	Sep 1, 2015
Priority date	—
Expiry date	Jan 25, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to bicyclic heterocyclic derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.